{"id":"W4415519791","doi":"10.1016/j.jtho.2025.09.032","title":"OA02.02 Molecular Residual Disease (MRD) Analysis from NeoADAURA: Neoadjuvant Osimertinib ± Chemotherapy in Resectable EGFRm NSCLC","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Osimertinib; Chemotherapy; Pathological; Disease; Stage (stratigraphy); Neoadjuvant therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003253217,0.0002570545,0.0002614659,0.0003785906,0.0002567581,0.0008777476,0.0002796935,0.0004498143,0.002422053],"category_scores_gemma":[0.0006778797,0.0001279383,0.0002705836,0.0002867961,0.0002552767,0.0002862004,0.0002224388,0.0003144254,0.0004092905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003611646,"about_ca_system_score_gemma":0.0003058512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001404192,"about_ca_topic_score_gemma":0.002764267,"domain_scores_codex":[0.9998306,0.00001720069,0.00002182838,0.00005040781,0.00003313384,0.00004678435],"domain_scores_gemma":[0.9997014,0.00006451517,0.0000709455,0.00002507989,0.0000384877,0.00009948848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.01036971,0.0002731218,0.8705971,0.00009299994,0.0001098861,0.007725687,0.000162556,0.0005107928,0.0765881,0.0002557814,0.001230074,0.03208425],"study_design_scores_gemma":[0.0002020994,0.002377615,0.9638814,0.00003697548,0.0003151332,0.01199724,0.0004526554,0.002219668,0.01289909,0.0003069229,0.005287484,0.00002375661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976255,0.000243504,0.00007530743,0.0000866043,0.00001515425,0.00001099278,0.0003153599,0.000008113866,0.00161955],"genre_scores_gemma":[0.998675,0.00009044838,0.0001040845,0.00006188873,0.0000143572,0.000006995707,0.0005570815,0.000005231699,0.0004847581],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002422053,"threshold_uncertainty_score":0.008102596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01204574346857208,"score_gpt":0.4340913452839231,"score_spread":0.4220456018153511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}